PCSK9 Gene Polymorphisms Associated With the Risk of Myocardial Infarction in Iranian Patients

Introduction: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulatory protein in lipid metabolism and a candidate gene in the etiology of cardiovascular diseases. The present study aimed to evaluate the prevalence and significance of PCSK9 rs505151 and rs11591147 variants with myoc...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Farshad Namordizadeh, Mahboobeh Nasiri
Formato:	article
Lenguaje:	EN
Publicado:	Zabol University of Medical sciences 2021
Materias:	pcsk9 polymorphism myocardial infarction iran Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/06bb239892ec4535895221244289f5b2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:06bb239892ec4535895221244289f5b2
record_format	dspace
spelling	oai:doaj.org-article:06bb239892ec4535895221244289f5b22021-11-17T09:55:12ZPCSK9 Gene Polymorphisms Associated With the Risk of Myocardial Infarction in Iranian Patients2476-664X10.34172/ijbsm.2021.10https://doaj.org/article/06bb239892ec4535895221244289f5b22021-06-01T00:00:00Zhttp://ijbsm.zbmu.ac.ir/PDF/ijbsm-21484https://doaj.org/toc/2476-664XIntroduction: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulatory protein in lipid metabolism and a candidate gene in the etiology of cardiovascular diseases. The present study aimed to evaluate the prevalence and significance of PCSK9 rs505151 and rs11591147 variants with myocardial infarction (MI) risk in the Iranian population. Patients and Methods: The frequency of the PCSK9 rs505151 and rs11591147 variants were compared between 600 cases of MI and 600 healthy age- and sex-matched individuals. Tetra-primer amplification refractory mutation system-polymerase chain reaction (T-ARMS PCR) was used for rs505151, and amplification refractory mutation system-polymerase chain (ARMS-PCR) was utilized to detect the rs11591147 polymorphism. Finally, SPSS and SHEsis software were applied for data analysis. Results: Carriers of the GG genotype of rs505151 polymorphism (OR: 1.57, 95% CI: 1.05–2.35, P = 0.02; age-adjusted; OR: 1.54, 95% CI: 1.03–2.32, P = 0.03) and at least one G-allele including GG+AG vs. AA (OR: 1.54, 95% CI: 1.04–2.28, P = 0.03; age-adjusted; OR: 1.51, 95% CI: 1.01–2.24, P = 0.04) have an increased risk of MI. No association between PCSK9 rs505151 alleles and MI risk was observed. The ratio of individuals with the rs11591147GT variant was higher in healthy individuals vs. patients with MI (48.6% vs. 41.7%), indicating a reduced risk of developing MI (OR: 0.75; 95% CI: 0.59–0.95; P = 0.01; age-adjusted; OR: 0.74; 95% CI: 0.58–0.95; P = 0.01). The carriers of at least one T allele (TT+GT vs. GG) (OR: 0.78; 95% CI: 0.62–0.98; P = 0.03; age-adjusted; OR: 0.78; 95% CI: 0.62–0.98; P = 0.03) showed a significant reduction in MI risk. The allelic frequencies at this polymorphic site did not differ between MI patients and healthy counterparts. No association was found between the haplotypes constructed from the alleles of these two polymorphisms. Conclusion: Our study provides the first evidence that PCSK9 gene polymorphisms may serve as independent prognostic markers for MI patients in Iran.Farshad NamordizadehMahboobeh NasiriZabol University of Medical sciencesarticlepcsk9 polymorphism myocardial infarction iran Medicine (General)R5-920ENInternational Journal of Basic Science in Medicine, Vol 6, Iss 2, Pp 57-63 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	pcsk9 polymorphism myocardial infarction iran Medicine (General) R5-920
spellingShingle	pcsk9 polymorphism myocardial infarction iran Medicine (General) R5-920 Farshad Namordizadeh Mahboobeh Nasiri PCSK9 Gene Polymorphisms Associated With the Risk of Myocardial Infarction in Iranian Patients
description	Introduction: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulatory protein in lipid metabolism and a candidate gene in the etiology of cardiovascular diseases. The present study aimed to evaluate the prevalence and significance of PCSK9 rs505151 and rs11591147 variants with myocardial infarction (MI) risk in the Iranian population. Patients and Methods: The frequency of the PCSK9 rs505151 and rs11591147 variants were compared between 600 cases of MI and 600 healthy age- and sex-matched individuals. Tetra-primer amplification refractory mutation system-polymerase chain reaction (T-ARMS PCR) was used for rs505151, and amplification refractory mutation system-polymerase chain (ARMS-PCR) was utilized to detect the rs11591147 polymorphism. Finally, SPSS and SHEsis software were applied for data analysis. Results: Carriers of the GG genotype of rs505151 polymorphism (OR: 1.57, 95% CI: 1.05–2.35, P = 0.02; age-adjusted; OR: 1.54, 95% CI: 1.03–2.32, P = 0.03) and at least one G-allele including GG+AG vs. AA (OR: 1.54, 95% CI: 1.04–2.28, P = 0.03; age-adjusted; OR: 1.51, 95% CI: 1.01–2.24, P = 0.04) have an increased risk of MI. No association between PCSK9 rs505151 alleles and MI risk was observed. The ratio of individuals with the rs11591147GT variant was higher in healthy individuals vs. patients with MI (48.6% vs. 41.7%), indicating a reduced risk of developing MI (OR: 0.75; 95% CI: 0.59–0.95; P = 0.01; age-adjusted; OR: 0.74; 95% CI: 0.58–0.95; P = 0.01). The carriers of at least one T allele (TT+GT vs. GG) (OR: 0.78; 95% CI: 0.62–0.98; P = 0.03; age-adjusted; OR: 0.78; 95% CI: 0.62–0.98; P = 0.03) showed a significant reduction in MI risk. The allelic frequencies at this polymorphic site did not differ between MI patients and healthy counterparts. No association was found between the haplotypes constructed from the alleles of these two polymorphisms. Conclusion: Our study provides the first evidence that PCSK9 gene polymorphisms may serve as independent prognostic markers for MI patients in Iran.
format	article
author	Farshad Namordizadeh Mahboobeh Nasiri
author_facet	Farshad Namordizadeh Mahboobeh Nasiri
author_sort	Farshad Namordizadeh
title	PCSK9 Gene Polymorphisms Associated With the Risk of Myocardial Infarction in Iranian Patients
title_short	PCSK9 Gene Polymorphisms Associated With the Risk of Myocardial Infarction in Iranian Patients
title_full	PCSK9 Gene Polymorphisms Associated With the Risk of Myocardial Infarction in Iranian Patients
title_fullStr	PCSK9 Gene Polymorphisms Associated With the Risk of Myocardial Infarction in Iranian Patients
title_full_unstemmed	PCSK9 Gene Polymorphisms Associated With the Risk of Myocardial Infarction in Iranian Patients
title_sort	pcsk9 gene polymorphisms associated with the risk of myocardial infarction in iranian patients
publisher	Zabol University of Medical sciences
publishDate	2021
url	https://doaj.org/article/06bb239892ec4535895221244289f5b2
work_keys_str_mv	AT farshadnamordizadeh pcsk9genepolymorphismsassociatedwiththeriskofmyocardialinfarctioniniranianpatients AT mahboobehnasiri pcsk9genepolymorphismsassociatedwiththeriskofmyocardialinfarctioniniranianpatients
_version_	1718425587870072832

PCSK9 Gene Polymorphisms Associated With the Risk of Myocardial Infarction in Iranian Patients

Ejemplares similares